Doneer nu
Alzheimercentrum Amsterdam

Publicaties 2013

Internationale publicaties:

  • Bakker, C., de Vugt, M. E., van Vliet, D., Verhey, F. R. J., Pijnenburg, Y. A., Vernooij-Dassen, M. J. F. J., Koopmans, R. T. C. M. The Use of Formal and Informal Care in Early Onset Dementia: Results From the NeedYD Study. American journal of geriatric psychiatry 2013;21(1):37-45. doi:10.1016/j.jagp.2012.10.004
  • Bakker, C., de Vugt, M. E., van Vliet, D., Verhey, F. R. J., Pijnenburg, Y. A., Vernooij-Dassen, M. J. F. J., Koopmans, R. T. C. M. Predictors of the Time to Institutionalization in Young- Versus Late-Onset Dementia: Results From the Needs in Young Onset Dementia (NeedYD) Study. Journal of the american medical directors association 2013;14(4):248-53. doi:10.1016/j.jamda.2012.09.011
  • Barkhof, F., Daams, M., Scheltens, P., Brashear, H. R., Arrighi, H. M., Bechten, A., Morris, K., McGovern, M., Wattjes, M. P. An MRI rating scale for amyloid-related imaging abnormalities with edema or effusion. AJNR American journal of neuroradiology 2013;34(8):1550-5. doi:10.3174/ajnr.A3475
  • Benedictus, M. R., Goos, J. D., Binnewijzend, M. A. A., Muller, M., Barkhof, F., Scheltens, P., Prins, N. D., van der Flier, W. M. Specific risk factors for microbleeds and white matter hyperintensities in Alzheimer’s disease. Neurobiology of aging 2013;34(11):2488-94. doi:10.1016/j.neurobiolaging.2013.04.023
  • Binnewijzend, M. A., Kuijer, J. P., Benedictus, M. R., van der Flier, W. M., Wink, A. M., Wattjes, M. P., van Berckel, B. N., Scheltens, P., Barkhof, F. Cerebral Blood Flow Measured with 3D Pseudocontinuous Arterial Spin-labeling MR Imaging in Alzheimer Disease and Mild Cognitive Impairment: A Marker for Disease Severity. Radiology 2013;267(1):221-30. Doi:10.1148/radiol.12120928
  • Boom, M., Olofsen, E., Neukirchen, M., Fussen, R., Hay, J., Groeneveld, G. J., Aarts, L., Sarton, E., Dahan, A. Fentanyl Utility Function: A Risk-Benefit Composite of Pain Relief and Breathing Responses. Anesthesiology 2013;119(3):663-74. Doi:10.1097/ALN.0b013e31829ce4cb
  • Bruggink, K. A., Jongbloed, W., Biemans, E. A. L. M., Veerhuis, R., Claassen, J. A. H. R., Kuiperij, H. B., Verbeek, M. M. Amyloid-beta oligomer detection by ELISA in cerebrospinal fluid and brain tissue. Analytical biochemistry 2013;433(2):112-20. Doi:10.1016/j.ab.2012.09.014
  • Clerx, L., Jacobs, H., I, Burgmans, S., Gronenschild, E., Uylings, H., Echavarri, C., Visser, P., Verhey, F., Aalten, P. Sensitivity of Different MRI-Techniques to Assess Gray Matter Atrophy Patterns in Alzheimer’s Disease is Region-Specific. Current alzheimer research 2013;10(9):940-51. WpR, VUmc NCA-NB
  • Clerx, L., van Rossum, I. A., Burns, L., Knol, D. L., Scheltens, P., Verhey, F., Aalten, P., Lapuerta, P., van de Pol, L., van Schijndel, R., de Jong, R., Barkhof, F., Wolz, R., Rueckert, D., Bocchetta, M., Tsolaki, M., Nobili, F., Wahlund, L. O., Minthon, L., Frolich, L., Hampel, H., Soininen, H., Visser, P. J. Measurements of medial temporal lobe atrophy for prediction of Alzheimer’s disease in subjects with mild cognitive impairment. Neurobiology of aging 2013;34(8):2003-13. Doi:10.1016/j.neurobiolaging.2013.02.002
  • Crutch, S. J., Schott, J. M., Rabinovici, G. D., Boeve, B. F., Cappa, S. F., Dickerson, B. C., Dubois, B., Graff-Radford, N. R., Krolak-Salmon, P., Lehmann, M., Mendez, M. F., Pijnenburg, Y. A. L., Ryan, N. S., Scheltens, P., Shakespeare, T., Tang-Wai, D. F., van der Flier, W. M., Bain, L., Carrillo, M. C., Fox, N. C. Shining a light on posterior cortical atrophy. Alzheimer’s & dementia : the journal of the Alzheimer’s Association 2013;9(4):463-5. Doi:10.1016/j.jalz.2012.11.004
  • Cummings, J. L., Dubois, B., Molinuevo, J. L., Scheltens, P. International Work Group Criteria for the Diagnosis of Alzheimer Disease. Medical clinics of north america 2013;97(3):363-+. Doi:10.1016/j.mcna.2013.01.001
  • Damian, M., Hausner, L., Jekel, K., Richter, M., Froelich, L., Almkvist, O., Boada, M., Bullock, R., De Deyn, P. P., Frisoni, G. B., Hampel, H., Jones, R. W., Kehoe, P., Lenoir, H., Minthon, L., Olde Rikkert, M. G. M., Rodriguez, G., Scheltens, P., Soininen, H., Spiru, L., Touchon, J., Tsolaki, M., Vellas, B., Verhey, F. R. J., Winblad, B., Wahlund, L. O., Wilcock, G., Visser, P. J. Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer’s disease in the european prospective DESCRIPA study. Dementia and geriatric cognitive disorders 2013;36(1-2):1-19. Doi:10.1159/000348354
  • de Haan, W., Mott, K., van Straaten, E. C. W., Scheltens, P., Stam, C. J. Activity Dependent Degeneration Explains Hub Vulnerability in Alzheimer’s Disease. Plos computational biology 2012;8(8):e1002582. Doi:10.1371/journal.pcbi.1002582
  • de Waal, H., Stam, C. J., de Haan, W., van Straaten, E. C. W., Blankenstein, M. A., Scheltens, P., van der Flier, W. M. Alzheimer’s disease patients not carrying the apolipoprotein E epsilon4 allele show more severe slowing of oscillatory brain activity. Neurobiology of aging 2013;34(9):2158-63. Doi:10.1016/j.neurobiolaging.2013.03.007
  • Duits, F. H., Kester, M. I., Scheffer, P. G., Blankenstein, M. A., Scheltens, P., Teunissen, C. E., van der Flier, W. M. Increase in Cerebrospinal Fluid F2-Isoprostanes is Related to Cognitive Decline in APOE epsilon4 Carriers. Journal of Alzheimer’s disease : JAD 2013;36(3):563-70. Doi:10.3233/JAD-122227
  • Elias-Sonnenschein, L. S., Helisalmi, S., Natunen, T., Hall, A., Paajanen, T., Herukka, S. K., Laitinen, M., Remes, A. M., Koivisto, A. M., Mattila, K. M., Lehtimaki, T., Verhey, F. R. J., Visser, P. J., Soininen, H., Hiltunen, M. Genetic Loci Associated with Alzheimer’s Disease and Cerebrospinal Fluid Biomarkers in a Finnish Case-Control Cohort. PloS one 2013;8(4). Doi:10.1371/journal.pone.0059676
  • Frisoni, G. B., Bocchetta, M., Chetelat, G., Rabinovici, G. D., de Leon, M. J., Kaye, J., Reiman, E. M., Scheltens, P., Barkhof, F., Black, S. E., Brooks, D. J., Carrillo, M. C., Fox, N. C., Herholz, K., Nordberg, A., Jack, C. R. J., Jagust, W. J., Johnson, K. A., Rowe, C. C., Sperling, R. A., Thies, W., Wahlund, L. O., Weiner, M. W., Pasqualetti, P., DeCarli, C. Imaging markers for Alzheimer disease: which vs how. Neurology 2013;81(5):487-500. Doi:10.1212/WNL.0b013e31829d86e8
  • Galasko, D., Golde, T. E., Scheltens, P. Progress in Alzheimer’s disease research circa 2013: Is the glass half empty or half full? Alzheimers research & therapy 2013;5(3):26. Doi:10.1186/alzrt180
  • Hooshmand, B., Polvikoski, T., Kivipelto, M., Tanskanen, M., Myllykangas, L., Erkinjuntti, T., Makela, M., Oinas, M., Paetau, A., Scheltens, P., van Straaten, E. C., Sulkava, R., Solomon, A. Plasma homocysteine, Alzheimer and cerebrovascular pathology: a population-based autopsy study. Brain 2013;136:2707-16. Doi:10.1093/brain/awt206
  • IJsselstijn, L., Papma, J. M., Dekker, L. J., Calame, W., Stingl, C., Koudstaal, P. J., Prins, N. D., Smitt, P. A., Luider, T. M. Serum proteomics in amnestic mild cognitive impairment. Proteomics 2013;13(16):2526-33. Doi:10.1002/pmic.201200190
  • Jacobs, H. I., Visser, P. J., Van Boxtel, M. P., Frisoni, G. B., Tsolaki, M., Papapostolou, P., Nobili, F., Wahlund, L. O., Minthon, L., Frolich, L., Hampel, H., Soininen, H., van de Pol, L., Scheltens, P., Tan, F. E., Jolles, J., Verhey, F. R. The association between white matter hyperintensities and executive decline in mild cognitive impairment is network dependent. Neurobiology of aging 2012;33(1):201. Doi:10.1016/j.neurobiolaging.2010.07.015
  • Jochemsen, H. M., Kloppenborg, R. P., de Groot, L. C. P. G., Kampman, E., Mali, W. P. T. M., van der Graaf, Y., Geerlings, M. I. Homocysteine, progression of ventricular enlargement, and cognitive decline: The Second Manifestations of ARTerial disease-Magnetic Resonance study. Alzheimers & dementia 2013;9(3):302-9. Doi:10.1016/j.jalz.2011.11.008
  • Jochemsen, H. M., Muller, M., Visseren, F. L., Scheltens, P., Vincken, K. L., Mali, W. P., van der Graaf, Y., Geerlings, M. I. Blood Pressure and Progression of Brain Atrophy The SMART-MR Study. JAMA neurology 2013;70(8):1046-53. Doi:10.1001/jamaneurol.2013.217
  • Jokinen, H., Schmidt, R., Ropele, S., Fazekas, F., Gouw, A. A., Barkhof, F., Scheltens, P., Madureira, S., Verdelho, A., Ferro, J. M., Wallin, A., Poggesi, A., Inzitari, D., Pantoni, L., Erkinjuntti, T. Diffusion changes predict cognitive and functional outcome: The LADIS study. Annals of neurology 2013;73(5):576-83. Doi:10.1002/ana.23802
  • Joling, K. J., Bosmans, J. E., van Marwijk, H. W. J., van der Horst, H. E., Scheltens, P., Vroomen, J. L. M., van Hout, H. P. J. The cost-effectiveness of a family meetings intervention to prevent depression and anxiety in family caregivers of patients with dementia: a randomized trial. Trials 2013;14:305. Doi:10.1186/1745-6215-14-305
  • Jongbloed, W., Kester, M. I., van der Flier, W. M., Veerhuis, R., Scheltens, P., Blankenstein, M. A., Teunissen, C. E. Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer’s disease study. Alzheimers & dementia 2013;9(3):276-83. Doi:10.1016/j.jalz.2012.01.004
  • Koedam, E. L. G. E., van der Vlies, A. E., van der Flier, W. M., Verwey, N. A., Koene, T., Scheltens, P., Blankenstein, M. A., Pijnenburg, Y. A. L. Cognitive correlates of cerebrospinal fluid biomarkers in frontotemporal dementia. Alzheimers & dementia 2013;9(3):269-75. Doi:10.1016/j.jalz.2011.12.007
  • Kohler, S., Hamel, R., Sistermans, N., Koene, T., Pijnenburg, Y. A. L., van der Flier, W. M., Scheltens, P., Visser, P. J., Aalten, P., Verhey, F. R. J., Ramakers, I. Progression to dementia in memory clinic patients without dementia: a latent profile analysis. Neurology 2013;81(15):1342-9. Doi:10.1212/WNL.0b013e3182a82536
  • Kooij, C.H. Van der, Dröes, R.M., Lange, J. de, Ettema, T.P., Cools, H., Tilburg, VanThe implementation of integrated emotion-oriented care; did it actually change the attitude, skills and time spending of trained caregivers? Dementia: The International Journal of Social Research and Practice, 09/2013,12(5):536-550
  • Kreisel, S. H., Blahak, C., Bazner, H., Inzitari, D., Pantoni, L., Poggesi, A., Chabriat, H., Erkinjuntti, T., Fazekas, F., Ferro, J. M., Langhorne, P., O’Brien, J., Scheltens, P., Visser, M. C., Wahlund, L. O., Waldemar, G., Wallin, A., Hennerici, M. G. Deterioration of Gait and Balance over Time: The Effects of Age-Related White Matter Change – The LADIS Study. Cerebrovascular diseases 2013;35(6):544-53. Doi:10.1159/000350725
  • Lehmann, M., Koedam, E. L., Barnes, J., Bartlett, J. W., Barkhof, F., Wattjes, M. P., Schott, J. M., Scheltens, P., Fox, N. C. Visual ratings of atrophy in MCI: prediction of conversion and relationship with CSF biomarkers. Neurobiology of aging 2013;34(1):73-82. Doi:10.1016/j.neurobiolaging.2012.03.010
  • Meesters, P. D., Comijs, H. C., Droes, R. M., de Haan, L., Smit, J. H., Eikelenboom, P., Beekman, A. T. F., Stek, M. L. The Care Needs of Elderly Patients With Schizophrenia Spectrum Disorders. American journal of geriatric psychiatry 2013;21(2):129-37. Doi:10.1016/j.jagp.2012.10.008
  • Moleiro, C., Madureira, S., Verdelho, A., Ferro, J. M., Poggesi, A., Chabriat, H., Erkinjuntti, T., Fazekas, F., Hennerici, M., O’Brien, J., Pantoni, L., Salvadori, E., Scheltens, P., Visser, M. C., Wahlund, L. O., Waldemar, G., Wallin, A., Inzitari, D. Confirmatory factor analysis of the Neuropsychological Assessment Battery of the LADIS study: A longitudinal analysis. Journal of clinical and experimental neuropsychology 2013;35(3):269-78. Doi:10.1080/13803395.2013.770822
  • Molinuevo, J. L., Cummings, J. L., Dubois, B., Scheltens, P. Preface. Medical clinics of north america 2013;97(3):XIII-XIXV. Doi:10.1016/j.mcna.2013.01.003
  • Möller, C., Vrenken, H., Jiskoot, L., Versteeg, A., Barkhof, F., Scheltens, P., van der Flier, W. M. Different patterns of gray matter atrophy in early- and late-onset Alzheimer’s disease. Neurobiology of aging 2013;34(8):2014-22. Doi:10.1016/j.neurobiolaging.2013.02.013
  • Morbelli, S., Perneczky, R., Drzezga, A., Frisoni, G. B., Caroli, A., van Berckel, B. N. M., Ossenkoppele, R., Guedj, E., Didic, M., Brugnolo, A., Naseri, M., Sambuceti, G., Pagani, M., Nobili, F. Metabolic Networks Underlying Cognitive Reserve in Prodromal Alzheimer Disease: A European Alzheimer Disease Consortium Project. Journal of nuclear medicine 2013;54(6):894-902. Doi:10.2967/jnumed.112.113928
  • Muller, M., Jochemsen, H., Visseren, F., Grool, A., Launer, L., van der Graaf, Y., Geerlings, M., I. Low blood pressure and antihypertensive treatment are independently associated with physical and mental health status in patients with arterial disease: the SMART study. Journal of internal medicine 2013;274(3):241-51. Doi:10.1111/joim.12069
  • Okroglic, S., Widmann, C. N., Urbach, H., Scheltens, P., Heneka, M. T. Clinical Symptoms and Risk Factors in Cerebral Microangiopathy Patients. PloS one 2013;8(2). Doi:10.1371/journal.pone.0053455
  • Ossenkoppele, R., Prins, N. D., Pijnenburg, Y. A., Lemstra, A. W., van der Flier, W. M., Adriaanse, S. F., Windhorst, A. D., Handels, R. L., Wolfs, C. A., Aalten, P., Verhey, F. R., Verbeek, M. M., van Buchem, M. A., Hoekstra, O. S., Lammertsma, A. A., Scheltens, P., van Berckel, B. N. Impact of molecular imaging on the diagnostic process in a memory clinic. Alzheimers & dementia 2013;9(4):414-21. Doi:10.1016/j.jalz.2012.07.003
  • Ossenkoppele, R., Prins, N. D., van Berckel, B. N. M. Amyloid imaging in clinical trials. Alzheimers research & therapy 2013;5(4):36. Doi:10.1186/1758-9193-5-36
  • Ossenkoppele, R., van der Flier, W. M., Zwan, M. D., Adriaanse, S. F., Boellaard, R., Windhorst, A. D., Barkhof, F., Lammertsma, A. A., Scheltens, P., van Berckel, B. N. M. Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia. Neurology 2013;80(4):359-65. WpR, VUmc NCA-NB
  • Palm, W. M., Ferrarini, L., van der Flier, W. M., Westendorp, R. G., Bollen, E. L., Middelkoop, H. A., Milles, J. R., van der Grond, J., van Buchem, M. A. Cerebral atrophy in elderly with subjective memory complaints. Journal of magnetic resonance imaging 2013;38(2):358-64. Doi:10.1002/jmri.23977
  • Papma, J. M., Seelaar, H., de Koning, I., Hasan, D., Reijs, A., Valkema, R., Prins, N. D., van Swieten, J. C. Episodic Memory Impairment in Frontotemporal Dementia; A Tc-99m-HMPAO SPECT Study. Current alzheimer research 2013;10(3):332-9. WpR, VUmc NCA-NB
  • Poggesi, A., Gouw, A., van der Flier, W., Pracucci, G., Chabriat, H., Erkinjuntti, T., Fazekas, F., Ferro, J. M., Hennerici, M., Langhorne, P., O’Brien, J. T., Visser, M. C., Wahlund, L. O., Waldemar, G., Wallin, A., Scheltens, P., Inzitari, D., Pantoni, L. Cerebral white matter changes are associated with abnormalities on neurological examination in non-disabled elderly: the LADIS study. Journal of neurology 2013;260(4):1014-21. Doi:10.1007/s00415-012-6748-3
  • Poil, S. S., de Haan, W., van der Flier, W. M., Mansvelder, H. D., Scheltens, P., Linkenkaer-Hansen, K. Integrative EEG biomarkers predict progression to Alzheimer’s disease at the MCI stage. Frontiers in aging neuroscience 2013;5:UNSP. Doi:10.3389/fnagi.2013.00058
  • Prestia, A., Caroli, A., van der Flier, W. M., Ossenkoppele, R., van Berckel, B., Barkhof, F., Teunissen, C. E., Wall, A. E., Carter, S. F., Scholl, M., Choo, I. H., Nordberg, A., Scheltens, P., Frisoni, G. B. Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease. Neurology 2013;80(11):1048-56. Doi:10.1212/WNL.0b013e3182872830
  • Prins, N. D., van der Flier, W. M., Brashear, H. R., Knol, D. L., van De Pol, L. A., Barkhof, F., Scheltens, P. Predictors of progression from mild cognitive impairment to dementia in the placebo-arm of a clinical trial population. Journal of Alzheimer’s disease : JAD 2013;36(1):79-85. Doi:10.3233/JAD-122233
  • Ramakers, I. H. G. B., Verhey, F. R. J., Scheltens, P., Hampel, H., Soininen, H., Aalten, P., Rikkert, M. O., Verbeek, M. M., Spiru, L., Blennow, K., Trojanowski, J. Q., Shaw, L. M., Visser, P. J. Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairment. Psychological medicine 2013;43(5):911-20. Doi:10.1017/S0033291712001870
  • Ravenscroft, T. A., Baker, M. C., Rutherford, N. J., Neumann, M., Mackenzie, I. R., Josephs, K. A., Boeve, B. F., Petersen, R., Halliday, G. M., Kril, J., van Swieten, J. C., Seeley, W. W., Dickson, D. W., Rademakers, R. Mutations in protein N-arginine methyltransferases are not the cause of FTLD-FUS. Neurobiology of aging 2013;34(9):UNSP. Doi:10.1016/j.neurobiolaging.2013.04.004
  • Scheltens, P. DEMENTIA Mild cognitive impairment-amyloid and beyond. Nature reviews neurology 2013;9(9):493-5. Doi:10.1038/nrneurol.2013.147
  • Schuitemaker, A., Kropholler, M. A., Boellaard, R., van der Flier, W. M., Kloet, R. W., van der Doef, T. F., Knol, D. L., Windhorst, A. D., Luurtsema, G., Barkhof, F., Jonker, C., Lammertsma, A. A., Scheltens, P., van Berckel, B. N. M. Microglial activation in Alzheimer’s disease: an (R)-PK11195 positron emission tomography study. Neurobiology of aging 2013;34(1):128-36. Doi:10.1016/j.neurobiolaging.2012.04.021
  • Sikkes, S. A. M., Knol, D. L., Pijnenburg, Y. A. L., de Lange-de Klerk, E., Uitdehaag, B. M. J., Scheltens, P. Validation of the Amsterdam IADL Questionnaire (c), a New Tool to Measure Instrumental Activities of Daily Living in Dementia. Neuroepidemiology 2013;41(1):35-41. Doi:10.1159/000346277
  • Sikkes, S. A. M., Pijnenburg, Y. A. L., Knol, D. L., de Lange-de Klerk, E., Scheltens, P., Uitdehaag, B. M. J. Assessment of Instrumental Activities of Daily Living in Dementia: Diagnostic Value of the Amsterdam Instrumental Activities of Daily Living Questionnaire. Journal of geriatric psychiatry and neurology 2013;26(4):244-50. Doi:10.1177/0891988713509139
  • Spies, P. E., Claassen, J. A. H. R., Peer, P. G. M., Blankenstein, M. A., Teunissen, C. E., Scheltens, P., van der Flier, W. M., Rikkert, M. G. M. O., Verbeek, M. M. A prediction model to calculate probability of Alzheimer’s disease using cerebrospinal fluid biomarkers. Alzheimers & dementia 2013;9(3):262-8. Doi:10.1016/j.jalz.2012.01.010
  • Tijms, B. M., Möller, C., Vrenken, H., Wink, A. M., de Haan, W., van der Flier, W. M., Stam, C. J., Scheltens, P., Barkhof, F. Single-Subject Grey Matter Graphs in Alzheimer’s Disease. PloS one 2013;8(3). Doi:10.1371/journal.pone.0058921
  • Tijms, B. M., Wink, A. M., de Haan, W., van der Flier, W. M., Stam, C. J., Scheltens, P., Barkhof, F. Alzheimer’s disease: connecting findings from graph theoretical studies of brain networks. Neurobiology of aging 2013;34(8):2023-36. Doi:10.1016/j.neurobiolaging.2013.02.020
  • van Berckel, B. N., Ossenkoppele, R., Tolboom, N., Yaqub, M., Foster-Dingley, J. C., Windhorst, A. D., Scheltens, P., Lammertsma, A. A., Boellaard, R. Longitudinal Amyloid Imaging Using C-11-PiB: Methodologic Considerations. Journal of nuclear medicine 2013;54(9):1570-6. Doi:10.2967/jnumed.112.113654
  • van de Glind, E. M. M., van Enst, W. A., van Munster, B. C., Olde Rikkert, M. G. M., Scheltens, P., Scholten, R. J. P. M., Hooft, L. Pharmacological treatment of dementia: a scoping review of systematic reviews. Dementia and geriatric cognitive disorders 2013;36(3-4):211-28. Doi:10.1159/000353892
  • van der Vlies, A. E., Staekenborg, S. S., dmiraal-Behloul, F., Prins, N. D., Barkhof, F., Vrenken, H., Reiber, J. H. C., Scheltens, P., van der Flier, W. M. Associations between Magnetic Resonance Imaging Measures and Neuropsychological Impairment in Early and Late Onset Alzheimer’s Disease. Journal of alzheimers disease 2013;35(1):169-78. Doi:10.3233/JAD-121291
  • van Harten, A. C., Smits, L. L., Teunissen, C. E., Visser, P. J., Koene, T., Blankenstein, M. A., Scheltens, P., van der Flier, W. M. Preclinical AD predicts decline in memory and executive functions in subjective complaints. Neurology 2013;81(16):1409-16. Doi:10.1212/WNL.0b013e3182a8418b
  • van Harten, A. C., Visser, P. J., Pijnenburg, Y. A., Teunissen, C. E., Blankenstein, M. A., Scheltens, P., van der Flier, W. M. Cerebrospinal fluid A beta 42 is the best predictor of clinical progression in patients with subjective complaints. Alzheimers & dementia 2013;9(5):481-7. Doi:10.1016/j.jalz.2012.08.004
  • van Swieten, J. C., Pijnenburg, Y. The role of the subgenual cingulate cortex in self-appraisal. Journal of neurology neurosurgery and psychiatry 2013;84(2):121. Doi:10.1136/jnnp-2012-303571
  • van Vliet, D., de Vugt, M. E., Aalten, P., Bakker, C., Pijnenburg, Y. A. L., Vernooij-Dassen, M. J. F. J., Koopmans, R. T. C. M., Verhey, F. R. J. Prevalence of Neuropsychiatric Symptoms in Young-Onset Compared to Late-Onset Alzheimer’s Disease – Part 1: Findings of the Two-Year Longitudinal NeedYD-Study. Dementia and geriatric cognitive disorders 2012;34(5-6):319-27. Doi:10.1159/000342824
  • van Vliet, D., de Vugt, M. E., Bakker, C., Pijnenburg, Y. A. L., Vernooij-Dassen, M. J. F. J., Koopmans, R. T. C. M., Verhey, F. R. J. Time to diagnosis in young-onset dementia as compared with late-onset dementia. Psychological medicine 2013;43(2):423-32. Doi:10.1017/S0033291712001122
  • van Vliet, D., de Vugt, M. E., Koehler, S., Aalten, P., Bakker, C., Pijnenburg, Y. A., Vernooij-Dassen, M. J., Koopmans, R. T., Verhey, F. R. Awareness and Its Association With Affective Symptoms in Young-onset and Late-onset Alzheimer Disease: A Prospective Study. Alzheimer disease & associated disorders 2013;27(3):265-71. Doi:10.1097/WAD.0b013e31826cffa5
  • Vellas, B., Carrillo, M. C., Sampaio, C., Brashear, H. R., Siemers, E., Hampel, H., Schneider, L. S., Weiner, M., Doody, R., Khachaturian, Z., Cedarbaum, J., Grundman, M., Broich, K., Giacobini, E., Dubois, B., Sperling, R., Wilcock, G. K., Fox, N. C., Scheltens, P., Touchon, J., Hendrix, S., Andrieu, S., Aisen, P. Designing drug trials for Alzheimer’s disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task Force. Alzheimer’s & dementia : the journal of the Alzheimer’s Association 2013;9(4):438-44. Doi:10.1016/j.jalz.2013.03.007
  • Verdelho, A., Madureira, S., Moleiro, C., Ferro, J. M., O’Brien, J. T., Poggesi, A., Pantoni, L., Fazekas, F., Scheltens, P., Waldemar, G., Wallin, A., Erkinjuntti, T., Inzitari, D. Depressive symptoms predict cognitive decline and dementia in older people independently of cerebral white matter changes: the LADIS study. Journal of neurology, neurosurgery, and psychiatry 2013;84(11):1250-4. Doi:10.1136/jnnp-2012-304191
  • Vermeiren, A. P. A., Bosma, H., Visser, P. J., Zeegers, M. P., Graff, C., Ewers, M., Frisoni, G. B., Frolich, L., Hampel, H., Jones, R. W., Kehoe, P. G., Lenoir, H., Minthon, L., Nobili, F. M., Rikkert, M. O., Rigaud, A. S., Scheltens, P., Soininen, H., Spiru, L., Tsolaki, M., Wahlund, L. O., Vellas, B., Wilcock, G., Elias-Sonnenschein, L. S., Verhey, F. R. J. The Association Between APOE epsilon 4 and Alzheimer-type Dementia Among Memory Clinic Patients is Confined to those with a Higher Education. The DESCRIPA Study. Journal of alzheimers disease 2013;35(2):241-6. Doi:10.3233/JAD-122182
  • Verwey, N. A., Hoozemans, J. J., Korth, C., van Royen, M. R., Prikulis, I., Wouters, D., Twaalfhoven, H. A., van Haastert, E. S., Schenk, D., Scheltens, P., Rozemuller, A. J., Blankenstein, M. A., Veerhuis, R. Immunohistochemical characterization of novel monoclonal antibodies against the N-terminus of amyloid beta-peptide. Amyloid-journal of protein folding disorders 2013;20(3):179-87. Doi:10.3109/13506129.2013.797389
  • Vos, S. J., Xiong, C., Visser, P. J., Jasielec, M. S., Hassenstab, J., Grant, E. A., Cairns, N. J., Morris, J. C., Holtzman, D. M., Fagan, A. M. Preclinical Alzheimer’s disease and its outcome: a longitudinal cohort study. Lancet neurology 2013;12(10):957-65. Doi:10.1016/S1474-4422(13)70194-7
  • Vos, S. J. B., van Rossum, I. A., Verhey, F., Knol, D. L., Soininen, H., Wahlund, L. O., Hampel, H., Tsolaki, M., Minthon, L., Frisoni, G. B., Froelich, L., Nobili, F., van der Flier, W., Blennow, K., Wolz, R., Scheltens, P., Visser, P. J. Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI. Neurology 2013;80(12):1124-32. Doi:10.1212/WNL.0b013e318288690c
  • Zarei, M., Beckmann, C. F., Binnewijzend, M. A., Schoonheim, M. M., Oghabian, M. A., Sanz-Arigita, E. J., Scheltens, P., Matthews, P. M., Barkhof, F. Functional segmentation of the hippocampus in the healthy human brain and in Alzheimer’s disease. Neuroimage 2013;66:28-35. Doi:10.1016/j.neuroimage.2012.10.071

Vakpublicaties:

  • Gossink, F., Dols, A., Kerssens, C. J., Scheltens, P., Stek, M. L., Pijnenburg, Y. A. L. . Nederlands tijdschrift voor geneeskunde 2013;157(42):A6370. VP, VUmc NCA-NB
  • Huber, E., Meiland, F., Stek, M., Dröes, R.M., Bootsma-vd Wiel, A. De overdracht van GGZ naar verpleeghuis. Continuiteit van zorg voor patiënten met dementie. Tijdschrift voor Ouderengeneeskunde, 2013, 04, 177-181
  • Meesters, P.D., Comijs, C., Dröes, R.M., Haan, L.de, Smit, J. Eikelenboom, P., Beekman, A.T.F., Stek, M. Ouderen met schizoofrenie; zorgbehoeften en zorgvernieuwing. MGv, 68 (4) 2013,174-183.
  • Scheltens, P., Twisk, J. W. R. . Nederlands tijdschrift voor geneeskunde 2013;157(0):A6721. VP, VUmc NCA-NB
  • van der Flier, W. M., Ossenkoppele, R., van Berckel, B. N. M., Scheltens, P. Vroegdiagnostiek van de ziekte van Alzheimer: de rol van Positron Emissie Tomografie (PET). Tijdschrift voor gerontologie en geriatrie 2013;44(4):190-1. VP, VUmc NCA-NB.10.1007/s12439-013-0033-5
  • Verberne, W. R., Snijders, T. J., Liem, K. S., Baakman, A. C., Veldhuijzen, D. S. . Nederlands tijdschrift voor geneeskunde 2013;157(5):A5434. VP, VUmc NCA-NB
  • Verhey, F. R. J., Visser, P. J. . Nederlands tijdschrift voor geneeskunde 2013;157(11):A5596. VP, VUmc NCA-NB

Boekhoofdstukken :

  • A.W. Lemstra, H. Seelaar, J.C. van Swieten. Primary Dementia Syndromes and Parkinsonism. In Oxford textbook of movement Disorders edited by DJ Burns, Oxford 2013

Dissertaties:

  • Goos J.D.C. Microbleeds in dementia: Connecting the dots  Vrije Universiteit Amsterdam 6 februari 2013. Promotoren: Ph. Scheltens, F. Barkhof, copromotor: W.M. van der Flier
  • Ossenkoppele R. Alzheimer PEThology Vrije Universiteit Amsterdam 8 mei 2013. Promotoren: Ph. Scheltens, A Lammertsma, copromotoren: B.N.M. van Berckel, W.M. van der Flier
  • Jochemsen H. Brain under pressure. Influences of blood pressure and angiotensin-converting enzyme on the brain. Vrije Universiteit Amsterdam 4 oktober 2013. Promotoren: Ph. Scheltens, Y. van der Graaf, copromotoren: M. Muler, M.I. Geerlings /li>
  • Van der Vlies A. Cognitive profiles in Alzheimer’s disease. Recognizing its many faces. Vrije Universiteit Amsterdam 27 november 2013. Promotor: Ph. Scheltens, copromotor: W.M. van der Flier
  • Van Rossum I. Diagnosis and prognosis of Alzheimer’s disease in subjects with mild cognitive impairment.  Vrije Universiteit Amsterdam 28 november 2013. Promotor: Ph. Scheltens, copromotor: P.J. Visser
Top
Volg ons via